default author photo

Roberto Sergio Accolla

University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”

Varese

Italy

SCHOLARLY PAPERS

2

DOWNLOADS

244

TOTAL CITATIONS

7

Scholarly Papers (2)

1.

Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients

Number of pages: 16 Posted: 29 Jun 2021
University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), Pisa University Hospital, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Department of Medicine and Surgery, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Chief Medical Officer, University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi” and University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”
Downloads 167 (449,518)
Citation 7

Abstract:

Loading...

BNT162b2 mRNA vaccine; COVID-19; SARS-CoV-2; saliva; IgA

2.

Mucosal Immune Response after the Booster Dose of the BNT162b2 COVID-19 Vaccine

Number of pages: 19 Posted: 08 Jun 2022
University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Department of Medicine and Surgery, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Chief Medical Officer, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi” and University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”
Downloads 77 (823,616)

Abstract:

Loading...

BNT162b2 mRNA vaccine, COVID-19, SARS-CoV-2, saliva, IgA